Projects per year
My research focuses on the neuronal changes caused by drugs of abuse, and how they relate to drug tolerance and addiction.
Morphine and related opiates such as heroin act by activating the µ-opioid receptor and are effective as analgesics, as well as being abused on the street. Following prolonged administration, tolerance occurs, whereby there is a need for escalating dose of that drug to maintain effect. This complicates pain-relief therapy as well as contributing to the social problems inherent in heroin addiction.
The mechanism(s) underlying opiate tolerance are poorly understood, but we have recently provided evidence that µ-opioid receptor desensitization may be a key process.
Interestingly, we have recently uncovered the fact that different ligands at the µ-opioid receptor can cause receptor desensitization and internalization by entirely different intracellular signalling mechanisms. On-going research is designed to investigate the precise molecular mechanisms underlying mu-opioid receptor desensitization and internalization, and determine precisely how these events relate to tolerance using behavioural methods.
Synaptic Plasticity and Drug Addiction
Intake of drugs of abuse such as heroin, cocaine and ethanol can result in compulsive drug use. Synaptic plasticity is thought to underlie memory formation, and as compulsive drug use is a learned behaviour, current interest in the field of drug addiction is focusing on the role of synaptic plasticity in the responses to drugs of abuse. On-going research is designed to gain a better understanding of the molecular processes underlying synaptic plasticity caused by drugs of abuse in areas of the brain such as the ventral tegmental area, nucleus accumbens and prefrontal cortex, how these processes can be modulated, and their effects on drug addiction.
We use a combination of electrophysiological approaches and real-time cell imaging coupled with behavioural measures of reward, analgesia and respiratory depression.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
- 1 Similar Profiles
Dive into details
Select a country/territory to view shared publications and projects
1/11/20 → 31/10/23
Project: Research council
1/06/15 → 30/06/16
Project: Research council
Sufcliffe, K. J., Corey, R. A., Alhosan, N., Cavallo, D., Groom, S., Santiago, M., Bailey, C., Charlton, S. J., Sessions, R. B., Henderson, G. & Kelly, E., 21 Mar 2022, In: Advances in Drug and Alcohol Research. 2, 10280.
Research output: Contribution to journal › Article › peer-reviewOpen Access
Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatementPalandri, J., Smith, S., Heal, D., Wonnacott, S. & Bailey, C., 1 Oct 2021, In: Journal of Psychopharmacology . 35, 10, p. 1204-1215 12 p.
Research output: Contribution to journal › Article › peer-reviewOpen Access3 Citations (SciVal)
A novel G protein-biased agonist at the d opioid receptor with analgesic efficacy in models of chronic painConibear, A. E., Asghar, J., Hill, R., Henderson, G., Borbely, E., Tekus, V., Helyes, Z., Palandri, J., Bailey, C. P., Starke, I., Williams, S., Kendall, D. & Kelly, E., 29 Feb 2020, In: Journal of Pharmacology and Experimental Therapeutics. 372, 2, p. 224-236 13 p.
Research output: Contribution to journal › Article › peer-reviewOpen Access30 Citations (SciVal)
A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitization through G protein-coupled receptor kinaseGroom, S., Blum, N. K., Conibear, A. E., Disney, A., Hill, R., Husbands, S. M., Li, Y., Toll, L., Kliewer, A., Schulz, S., Henderson, G., Kelly, E. & Bailey, C. P., 27 Nov 2020, (E-pub ahead of print) In: British Journal of Pharmacology.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile1 Citation (SciVal)11 Downloads (Pure)
Kliewer, A., Gillis, A., Hill, R., Schmidel, F., Bailey, C., Kelly, E., Henderson, G., Christie, M. J. & Schulz, S., 8 Jun 2020, In: British Journal of Pharmacology. 177, 13, p. 2923-2931 9 p.
Research output: Contribution to journal › Article › peer-reviewOpen Access108 Citations (SciVal)